ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

PCSA Processa Pharmaceuticals Inc

2.14
-0.12 (-5.31%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Processa Pharmaceuticals Inc PCSA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.12 -5.31% 2.14 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.30 2.15 2.30 2.17 2.26
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202407:00GLOBEProcessa Pharmaceuticals Names Dr. Steven Cha Senior Vice..
11/4/202407:00GLOBEProcessa Pharmaceuticals Presents Two Abstracts at the AACR..
28/3/202407:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest Biotech..
25/3/202407:15GLOBEProcessa Pharmaceuticals to Present Data at the American..
21/2/202416:25EDGAR2Form 8-K - Current report
21/2/202407:15GLOBEProcessa Pharmaceuticals to Present at the 2024 BIO CEO &..
14/2/202412:00GLOBEProcessa Pharmaceuticals to Present at The Winter Wrap-Up..
06/2/202407:30EDGAR2Form 8-K - Current report
06/2/202407:30GLOBEProcessa Pharmaceuticals Regains Compliance with Nasdaq..
01/2/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202415:22GLOBEProcessa Pharmaceuticals Announces Closing of $7.0 Million..
31/1/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202409:46EDGAR2Form 8-K - Current report
29/1/202415:15EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
28/1/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202408:04GLOBEProcessa Pharmaceuticals Announces Pricing of $7.0 Million..
25/1/202407:35EDGAR2Form 8-K - Current report
25/1/202407:30GLOBEProcessa Pharmaceuticals Announces Successful Completion of..
19/1/202407:00EDGAR2Form 8-K - Current report
19/1/202406:45GLOBEProcessa Pharmaceuticals Announces Expansion of NGC-Cap..
18/1/202407:30EDGAR2Form 8-K - Current report
18/1/202406:45GLOBEProcessa Pharmaceuticals to Effect a 1-for-20 Reverse Stock..
08/1/202415:30EDGAR2Form 8-K - Current report
02/1/202416:06GLOBEProcessa Pharmaceuticals to Present at the Biotech Showcase..
29/12/202307:55EDGAR2Form S-1 - General form for registration of securities under..
19/12/202308:00EDGAR2Form 8-K - Current report
19/12/202308:00GLOBEProcessa Pharmaceuticals Provides Interim Analysis from..
13/12/202308:00GLOBEProcessa Pharmaceuticals Announces Successful Phase 2..
05/12/202316:18EDGAR2Form 8-K - Current report
30/11/202307:15GLOBEProcessa Pharmaceuticals to Present at the MedInvest..
29/11/202307:15GLOBEProcessa Pharmaceuticals Issues Letter to Shareholders..
16/11/202314:10EDGAR2Form 8-K - Current report
15/11/202310:30EDGAR2Form 8-K - Current report
13/11/202315:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:45EDGAR2Form 8-K - Current report
13/11/202312:40GLOBEProcessa Pharmaceuticals, Inc. Mourns the Sudden Passing of..
09/11/202307:15GLOBEProcessa Pharmaceuticals to Present at the 20th Orphan Drugs..
01/11/202307:15GLOBEProcessa Pharmaceuticals Announces Formation of Oncology..
16/10/202308:15EDGAR2Form 8-K - Current report
13/10/202312:08GLOBEProcessa Pharmaceuticals to Present at the ThinkEquity..
12/10/202317:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202317:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202316:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202309:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
05/10/202309:00EDGAR2Form DEF 14A - Other definitive proxy statements

Su Consulta Reciente

Delayed Upgrade Clock